183 related articles for article (PubMed ID: 19496118)
1. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
[TBL] [Abstract][Full Text] [Related]
2. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
3. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
[TBL] [Abstract][Full Text] [Related]
4. Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries.
Pendyala L; Yin X; Li J; Shinke T; Xu Y; Chen JP; King SB; Colley K; Goodchild T; Chronos N; Hou D
EuroIntervention; 2010 May; 6(1):126-33. PubMed ID: 20542808
[TBL] [Abstract][Full Text] [Related]
5. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
6. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
8. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
[TBL] [Abstract][Full Text] [Related]
9. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
[TBL] [Abstract][Full Text] [Related]
10. A successful experimental model for intimal hyperplasia prevention using a resveratrol-delivering balloon.
Tolva V; Mazzola S; Zerbi P; Casana R; Albertini M; Calvillo L; Selmin F; Cilurzo F
J Vasc Surg; 2016 Mar; 63(3):788-94. PubMed ID: 25446284
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
12. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
[TBL] [Abstract][Full Text] [Related]
13. A novel polymer-free ciglitazone-coated vascular stent: in vivo and ex vivo analysis of stent endothelialization in a rabbit iliac artery model.
Otto S; Jaeger K; Kolodgie FD; Muehlstaedt D; Franz M; Bischoff S; Schubert H; Figulla HR; Virmani R; Poerner TC
Oncotarget; 2016 Sep; 7(36):57571-57580. PubMed ID: 27613845
[TBL] [Abstract][Full Text] [Related]
14. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits.
Narita H; Chen S; Komori K; Kadomatsu K
J Vasc Surg; 2008 Jun; 47(6):1322-9. PubMed ID: 18353604
[TBL] [Abstract][Full Text] [Related]
15. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
16. Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1.
Hyvelin JM; Maurel B; Uzbekov R; Motterlini R; Lermusiaux P
J Vasc Surg; 2010 Feb; 51(2):417-28. PubMed ID: 20022212
[TBL] [Abstract][Full Text] [Related]
17. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
Huang C; Zhao J; Zhu Y
J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
[TBL] [Abstract][Full Text] [Related]
18. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
20. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
Huang C; Zhou M; Zheng X
J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
